Abstract
Possible involvement of reversible phosphorylation and dephosphorylation of myosin light chain (MLC) by myosin light chain kinase (MLCK) and protein phosphatases (PPases), respectively, in the Ca++-calmodulin-dependent inhibition of renin secretion was investigated with the use of putative MLCK inhibitor ML-7 [1-(5-iodonaphthalene-1-sulfonyl)-1H-hexahydro-1,4-diazepine] and PPase type1 (PPase-1) and type 2A (PPase-2A) inhibitor calyculin A. ML-7 (1 × 10−6 to 3 × 10−5 M) increased renin secretion in vitro from rat renal cortical slices under “resting” conditions in a concentration-dependent manner with maximal 2.5-fold stimulation. Furthermore, Ca++-induced inhibition of renin secretion in depolarizing K+-rich Krebs-Ringer bicarbonate not only was prevented completely but also reversed by ML-7 in a concentration-dependent and reversible manner. On the other hand, calyculin A (3 × 10−6 M) blocked both effects of ML-7 on stimulation and reversal of renin secretion independently of intracellular Ca++ concentrations. Such antagonistic effects of ML-7 and calyculin A on renin secretion most likely resulted from their respective effects on the level of MLC phosphorylation: ML-7 stimulates renin secretion by decreasing phosphorylation of MLC through its inhibition of MLCK, whereas calyculin A inhibits secretion by increasing phosphorylation of MLC through its inhibition of PPase-1. By inference from these results, MLC may be the target protein involved in regulation of the renin secretory process by Ca++: Ca++-calmodulin phosphorylates MLC via activating MLCK and thereby inhibits renin secretion, whereas dephosphorylation of phosphorylated MLC by PPase-1 reverses the inhibited secretion. We therefore conclude that reversible phosphorylation of MLC may be an important biochemical step determining the rate of renin secretion from the juxtaglomerular cell.
Footnotes
-
Send reprint requests to: Chun Sik Park, M.D., Ph.D., Department of Physiology, University of Ulsan College of Medicine, 388–1 Poongnap Dong, Songpa Ku, Seoul 138–736, Korea.
-
↵1 This work was supported by grants from the Korea Science and Engineering Foundation (961–0701-002–2), the Academic Research Fund to the Ministry of Education, Republic of Korea (BM96–197), and the Asan Social Welfare Foundation, Seoul, Korea
-
↵2 Present address: Department of Physiology, Jeonbuk National University Medical School, Jeonju, Korea.
-
↵3 Present address: Department of Thoracic Surgery, Cardiovascular Center, Yeonsei University College of Medicine, Seoul, Korea.
- Abbreviations:
- JG cell
- juxtaglomerular cell
- ML-7
- 1-(5-iodonaphthalene-1-sulfonyl)-1H-hexahydro-1,4-diazepine
- ML-9
- 1-(5-chloronaphthalene-1-sulfonyl)-1H-hexahydro-1,4-diazepine
- MLC20
- 20-kdalton myosin light chain
- MLCK
- myosin light chain kinase
- PPase-1
- protein phosphatase type 1
- PPase-2A
- protein phosphatase type 2A
- KRB
- Krebs-Ringer bicarbonate
- ANG I
- angiotensin I
- Received September 2, 1997.
- Accepted February 23, 1998.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|